Macrogenics (MGNX) Operating Income Growth (1y) (2013 - 2026)
Macrogenics (MGNX) Operating Income Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 472.40 Bn | 467.61 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 122.23 Bn | 114.98 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn | 145.20% |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | 1,386.07% |
| 10 | Macrogenics | 249.04 Mn | 182.52 Mn | - | 21.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.55% |
| Dec 31, 2025 | 77.11% |
| Sep 30, 2025 | -65.61% |
| Jun 30, 2025 | 36.82% |
| Mar 31, 2025 | 20.70% |
| Dec 31, 2024 | -7.06% |
| Sep 30, 2024 | 252.64% |
| Jun 30, 2024 | -29.40% |
| Mar 31, 2024 | -39.88% |
| Dec 31, 2023 | -511.87% |
| Sep 30, 2023 | -42.26% |
| Jun 30, 2023 | -7.54% |
| Mar 31, 2023 | 42.34% |
| Dec 31, 2022 | 120.58% |
| Sep 30, 2022 | 52.90% |
| Jun 30, 2022 | -3.80% |
| Mar 31, 2022 | -29.92% |
| Dec 31, 2021 | -2,583.69% |
| Sep 30, 2021 | -46.64% |
| Jun 30, 2021 | 14.86% |